Robert Iv Dickey is Chief Financial Officer of ReShape Lifesciences Inc.. Currently has a direct ownership of 762 shares of RSLS, which is worth approximately $11,948. The most recent transaction as insider was on Aug 15, 2025, when has been sold 762 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 762
n/a 3M change
n/a 12M change
Total Value Held $11,948

Robert IV Dickey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 15 2025
BUY
Grant, award, or other acquisition
-
762 Added 50.0%
762 Common Stock
RID

Robert Iv Dickey

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on RSLS

Follow ReShape Lifesciences Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RSLS shares.

Notify only if

Insider Trading

Get notified when an Re Shape Lifesciences Inc. insider buys or sells RSLS shares.

Notify only if

News

Receive news related to ReShape Lifesciences Inc.

Track Activities on RSLS